Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00805636
What this trial is testing

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

Who this might be right for
Brain MetastasesSolid Tumors
Aposense Ltd. 30
Very early researchStudy completedNCT04689204
What this trial is testing

CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
He Huang 3
Testing effectiveness (Phase 2)WithdrawnNCT05740449
What this trial is testing

HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Testing effectiveness (Phase 2)Study completedNCT00423124
What this trial is testing

Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies

Who this might be right for
Hematological Malignancies
AGC Biologics S.p.A. 57
Not applicableStudy completedNCT00897260
What this trial is testing

Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders

Who this might be right for
Hematological MalignancyBone Marrow Failure Syndrome
University of British Columbia 27
Not applicableStudy completedNCT02164071
What this trial is testing

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Who this might be right for
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple Myeloma+1 more
Celgene 363
Early research (Phase 1)Study completedNCT02017613
What this trial is testing

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies

Who this might be right for
Lymphoma, B-CellT-Cell Lymphoma
Rhizen Pharmaceuticals SA 35
Testing effectiveness (Phase 2)Looking for participantsNCT06066203
What this trial is testing

GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies

Who this might be right for
Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02420873
What this trial is testing

An Open-label Phase II Study of Lorvotuzumab Mertansine

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT04712942
What this trial is testing

Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesMinimal Residual Disease
University of Leipzig 14
Not applicableStudy completedNCT02906254
What this trial is testing

Early Antibiotic Discontinuation in FUO

Who this might be right for
Febrile NeutropeniaHematological Malignancy
University Hospital, Brest 123
Testing effectiveness (Phase 2)Study completedNCT04103879
What this trial is testing

US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

Who this might be right for
High Risk Hematological MalignancyCord Blood Transplant
ExCellThera inc. 30
Not applicableLooking for participantsNCT03802773
What this trial is testing

Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)

Who this might be right for
Cord Blood TransplantationHematological Malignancies
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 10
Early research (Phase 1)Study completedNCT00697346
What this trial is testing

Study of MLN8237 in Participants With Advanced Hematological Malignancies

Who this might be right for
B-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell Lymphoma+10 more
Millennium Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT00312429
What this trial is testing

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

Who this might be right for
Hematologic Neoplasms
Duke University 34
Large-scale testing (Phase 3)UnknownNCT00883961
What this trial is testing

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematological Disease
Charite University, Berlin, Germany 60
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Not applicableEnrolling By InvitationNCT05041309
What this trial is testing

Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies

Who this might be right for
Solid and Hematological MalignanciesAutoimmune Diseases
Kite, A Gilead Company 1,500
Early research (Phase 1)Ended earlyNCT01695733
What this trial is testing

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

Who this might be right for
Neoplasms
Washington University School of Medicine 21
Post-approval studies (Phase 4)Study completedNCT02880709
What this trial is testing

The Effect of Special Diets in Hematological Cancer Patients

Who this might be right for
Hematological Malignancy
Jens Rikardt Andersen 32
Next Page